Donga ST announced that they received sales approval of Sivextro in the United States followed by South Korea, Europe

Recently, Donga ST announced that they received sales approval of superbacteria target antibiotic Sivextro in the United States followed by South Korea, Europe, Canada, Japan, and China.

Three companies, including Donga ST, Cubist, and Bayer implement marketing in global market.

First, bridging study is currently in progress in domestic market, and Sivextro is expected to be released in next ...